Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Patel

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomasF Meric, M Milas, K K Hunt, et al.
The Annals of Thoracic Surgery|February 2, 2000
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121L Y Lee, S R Patel, N R Hackett, et al.
Journal of Vascular Surgery|May 12, 1998
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusionC A Mack, C J Magovern, K T Budenbender, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 1999
The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitorsF M Martin, R P Beckett, C L Bellamy, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 1998
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heartC A Mack, S R Patel, E A Schwarz, et al.
Clinical Pharmacology and Therapeutics|March 5, 2010
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African AmericansD Voora, D C Koboldt, C R King, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma CommitteeB L Eisenburg, K Alektiar, M Ballo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomasJ B Fleming, R S Berman, S C Cheng, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 1, 1997
The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemiaN I Wood, F C Barone, C D Benham, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomasF Meric, M Milas, K K Hunt, et al.
The Annals of Thoracic Surgery|February 2, 2000
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121L Y Lee, S R Patel, N R Hackett, et al.
Journal of Vascular Surgery|May 12, 1998
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusionC A Mack, C J Magovern, K T Budenbender, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 1999
The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitorsF M Martin, R P Beckett, C L Bellamy, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 1998
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heartC A Mack, S R Patel, E A Schwarz, et al.
Clinical Pharmacology and Therapeutics|March 5, 2010
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African AmericansD Voora, D C Koboldt, C R King, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma CommitteeB L Eisenburg, K Alektiar, M Ballo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomasJ B Fleming, R S Berman, S C Cheng, et al.
Circulation|August 3, 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 1, 1997
The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemiaN I Wood, F C Barone, C D Benham, et al.
Pageof 17